Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NASA Astronaut and Physiologist Dr Jessica Meir unveils The Physiological Society blue plaque in honour of fellow pioneering Physiologist and Scientific Explorer Mabel FitzGerald.

Jessica Meir and David Paterson with Mabel FitzGerald Plaque

On Tuesday 16 November 2021, NASA Astronaut, Marine Biologist and Comparative Physiologist Dr Jessica U. Meir, Ph.D. visited the Department of Physiology, Anatomy & Genetics (DPAG) to unveil a new plaque honouring one of DPAG's earliest pioneering women, Mabel Purefoy FitzGerald

Dr Meir made history in 2019 by being part of the historic first all-female spacewalk, and she is ready to do it again by attempting to be the first woman on the moon. With NASA’s Artemis programme set to land the first woman on the moon in 2024, Dr Meir hopes she can fulfil her childhood dream of walking in the footsteps of Neil Armstrong.

The new plaque she unveiled this week is part of an ongoing project by The Physiological Society to erect blue plaques across the United Kingdom and Ireland celebrating and recognising institutions where distinguished physiologists have made significant contributions to the discipline. The Society's plaques ultimately honour outstanding physiologists who have contributed to the advancement of physiology through their discoveries while leaving a legacy beyond their lifetime.

Read the full story on the DPAG website

Dr Jessica Meir also delivered the Sherrington Prize Lecture: Public Understanding of Science, inspiring the next generation of scientists and explorers.

Similar stories

Oxford University wins prestigious Queen’s Anniversary Prize

Her Majesty The Queen has approved the award of The Queen’s Anniversary Prizes to twenty-one higher and further education institutions, including Oxford University, in the most recent round of the independently reviewed scheme. This prestigious award is the highest national honour available to universities and FE colleges across the UK.

Jenner Institute named Covid Innovation Heroes

The team at the University of Oxford’s Jenner Institute has been celebrated for their global pandemic work by The Oxford Trust’s Covid Innovation Heroes Award­ 2021.

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.